ReviewKidney international supplements2022

Considerations for the future: current and future treatment paradigms with mineralocorticoid receptor antagonists-unmet needs and underserved patient cohorts.

Murray EpsteinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.